Status:
COMPLETED
Hypnosis in Virtual Reality in Patients in Protector Isolation Room for Aplasia in Clinical Hematology.
Lead Sponsor:
Hôpital Privé Sévigné
Conditions:
Aplasia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hematology patients are frequently treated in hospital for aplasia. Patients are then placed in protective isolation room. This situation of protective isolation can represent a significant source of ...
Detailed Description
After verifying the patient's eligibility criteria and obtaining the signed informed consent form, the patient is randomized to the arm receiving hypnosis in virtual reality or to the control arm. The...
Eligibility Criteria
Inclusion
- Patient aged ≥ 18 years.
- Haematological pathology
- Patient hospitalized in protective isolation for aplasia defined by a rate of polymorphonuclear neutrophils \<0.5 G / L.
- Patient having signed his informed consent.
- Patient with social security coverage.
- Patient treated and monitored in the center for the duration of the study (maximum 1 month)
Exclusion
- Patient unable to undergo protocol monitoring for psychological, social, family or geographic reasons.
- Patient deprived of his liberty or under guardianship.
- Patient with an underlying or concomitant pathology incompatible with inclusion in the trial, whether psychiatric or somatic
- Patient with a contraindication to the use of virtual reality (psychiatric disorders, unbalanced epilepsy, visual or hearing disorders).
Key Trial Info
Start Date :
June 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04794608
Start Date
June 17 2021
End Date
February 28 2024
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé Sévigné
Cesson-Sévigné, France, 35520